Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Bayer AG NA (BAYGn)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
26.46 -0.51    -1.87%
15/04 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  DE000BAY0017 
WKN:  BAY001
  • Prev. Close: 26.46
  • Open: 26.71
  • Day's Range: 26.05 - 26.86
Bayer 26.46 -0.51 -1.87%

ETR:BAYGn Financials

 
A brief overview of the ETR:BAYGn financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Bayer AG over time.

Bayer Aktiengesellschaft reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 47,637 million compared to EUR 50,739 million a year ago. Net loss was EUR 2,941 million compared to net income of EUR 4,150 million a year ago. Basic loss per share from continuing operations was EUR 2.99 compared to basic earnings per share from continuing operations of EUR 4.22 a year ago. Diluted loss per share from continuing operations was EUR 2.99 compared to diluted earnings per share from continuing operations of EUR 4.22 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

BAYGN Income Statement

Gross margin TTM 58.55%
Operating margin TTM 16.37%
Net Profit margin TTM -6.17%
Return on Investment TTM 8.65%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 11862 10342 11044 14389
Gross Profit 7379 5530 6372 8656
Operating Income 9376 -3594 1534 2973
Net Income 1337 -4569 -1887 2178

BAYGN Balance Sheet

Quick Ratio MRQ 0.68
Current Ratio MRQ 1.27
LT Debt to Equity MRQ 113.07%
Total Debt to Equity MRQ 136.68%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 116259 117242 121667 125052
Total Liabilities 83181 83695 84543 84035
Total Equity 33078 33547 37124 41017

BAYGN Cash Flow Statement

Cash Flow/Share TTM 5.21
Revenue/Share TTM 48.49
Operating Cash Flow  19.03%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 5607 2576 484 -3550
Cash From Investing Activities -3884 -138 -1097 1602
Cash From Financing Activities -2453 -160 272 1662
Net Change in Cash -908 2334 -373 -317
* In Millions of EUR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

BAYGn Comments

Write your thoughts about Bayer AG NA
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Luu Mrv
Luu Mrv 12 hours ago
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
is not matter of any results ! is matter of the lawsuit! that's all.
Reply
0 0
Report
Ovidiu Ivan
Ovidiu Ivan 15 hours ago
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
it is a very poor company. to much debt. The price is good if you believe that the new CEO will put the company towards a good destination. At this price you can risk some money and speculate that is going to deliver some decent results in Q1
Reply
0 0
Report
Luca ZeStonks
Luca ZeStonks Apr 11, 2024 10:37AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Poor longs getting knocked out again. 26 and then 24 follow
Reply
1 0
Report
amt hun
amt hun Mar 07, 2024 8:35AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I bet the Chinese and the Indian investors are piling up the shares like crazy at this price.
Reply
9 1
Report
Luca ZeStonks
Luca ZeStonks Mar 07, 2024 3:56AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Next knock out 25 then 24, then from July recovery
Reply
2 1
Report
Luca ZeStonks
Luca ZeStonks Mar 05, 2024 8:40AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
27 knock out coming soon
Reply
2 1
Report
Luca ZeStonks
Luca ZeStonks Mar 05, 2024 8:40AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
KNOCKED OUT BOOM
Reply
1 0
Report
Luu Mrv
Luu Mrv Mar 05, 2024 5:48AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
from ext week will rise over 30. ;)
Reply
0 2
Report
Luca ZeStonks
Luca ZeStonks Feb 29, 2024 8:13AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Next trial loss lets go to 24 euros
Reply
3 0
Report
ollie susnea
ollie susnea Feb 29, 2024 8:13AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
then I will buy
Reply
1 0
Report
amt hun
amt hun Feb 29, 2024 8:13AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
bayer is winning the overwhelming majority of the trials, but those don't make it to the news.
Reply
1 0
Report
Luca ZeStonks
Luca ZeStonks Feb 29, 2024 8:13AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
5k+ lawsuits to go
Reply
0 0
Report
Giuseppe Esposito
Giuseppe Esposito Feb 19, 2024 12:11PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Ciao , ho letto che tagliano i dividendi per i prossimi 3 anni, vi risulta?
Reply
1 0
Report
Anto Dero
Anto Dero Feb 19, 2024 12:11PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
si ma non di molto, solo del 95.4%. Stai sereno!
Reply
2 0
Report
Luu Mrv
Luu Mrv Feb 19, 2024 12:11PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
ahahah danno il minimo sindacale sulla base della legge tedesca
Reply
0 0
Report
Luca ZeStonks
Luca ZeStonks Feb 14, 2024 3:50AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Next knowck out level 26.9
Reply
1 1
Report
Luu Mrv
Luu Mrv Feb 14, 2024 3:50AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
how do you predict that price ?
Reply
0 0
Report
Luca ZeStonks
Luca ZeStonks Feb 14, 2024 3:50AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
100%. The next trial outcome is imminent and it will be lost (guaranteed).
Reply
0 1
Report
Luu Mrv
Luu Mrv Feb 14, 2024 3:50AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
you look like Nostradamus! how could you be so sure ! I don't understand
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email